Please assess the completion status of the following clinical trial:

Trial Title: Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* congenital or acquired gastrointestinal disorder~* age less than 5 days of life~Exclusion Criteria:~* congenital intrauterine infection know to be associated with liver involvement~* known structural liver abnormalities~* known genetic disorders (trisomy 21, 13, and 18)~* inborn errors of metabolism~* infants meeting the criteria for terminal illness (ph:6.8\>2 hours)

- Gender: ALL
- Minimum Age: 1 Minute
- Maximum Age: 5 Days
- Healthy Volunteers: f

Study Arms:
- low dose intravenous fat emulsion (Type: EXPERIMENTAL): Subjects in this arm will receive approximately 1 g/kg/d IV of intravenous soybean oil (Intralipid).
- standard dose intravenous fat emulsion (Type: ACTIVE_COMPARATOR): Subjects in this arm will receive approximately 3 g/kg/d IV of intravenous soybean oil (Intralipid).

Based on this trial design, predict the completion outcome and termination type (if applicable).